首页 > 最新文献

Journal of Bone and Joint Infection最新文献

英文 中文
It is time for a unified definition of native vertebral osteomyelitis: a framework proposal. 是时候给原发性脊椎骨髓炎下一个统一的定义了:框架建议。
IF 1.8 Q3 INFECTIOUS DISEASES Pub Date : 2024-06-24 eCollection Date: 2024-01-01 DOI: 10.5194/jbji-9-173-2024
Francesco Petri, Omar Mahmoud, Said El Zein, Ahmad Nassr, Brett A Freedman, Jared T Verdoorn, Aaron J Tande, Elie F Berbari

In recent years, there has been a notable increase in research output on native vertebral osteomyelitis (NVO), coinciding with a rise in its incidence. However, clinical outcomes remain poor, due to frequent relapse and long-term sequelae. Additionally, the lack of a standardized definition and the use of various synonyms to describe this condition further complicate the clinical understanding and management of NVO. We propose a new framework to integrate the primary diagnostic tools at our disposal. These collectively fall into three main domains: clinical, radiological, and direct evidence. Moreover, they and can be divided into seven main categories: (a) clinical features, (b) inflammatory biomarkers, (c) imaging techniques, microbiologic evidence from (d) blood cultures and (e) invasive techniques, (f) histopathology, and (g) empirical evidence of improvement following the initiation of antimicrobial therapy. We provide a review on the evolution of these techniques, explaining why no single method is intrinsically sufficient to formulate an NVO diagnosis. Therefore, we argue for a consensus-driven, multi-domain approach to establish a comprehensive and universally accepted definition of NVO to enhance research comparability, reproducibility, and epidemiological tracking. Ongoing research effort is needed to refine these criteria further, emphasizing collaboration among experts through a Delphi method to achieve a standardized definition. This effort aims to streamline research, expedite accurate diagnoses, optimize diagnostic tools, and guide patient care effectively.

近年来,随着原发性脊椎骨髓炎(NVO)发病率的上升,有关该病的研究成果也显著增加。然而,由于经常复发和长期后遗症,临床疗效仍然不佳。此外,由于缺乏标准化的定义,且使用各种同义词来描述这种疾病,使得临床上对 NVO 的理解和管理更加复杂。我们提出了一个新的框架来整合我们所掌握的主要诊断工具。这些工具统称为三个主要领域:临床、放射学和直接证据。此外,它们还可分为七大类:(a) 临床特征;(b) 炎症生物标志物;(c) 影像学技术;(d) 血液培养和 (e) 侵袭性技术提供的微生物学证据;(f) 组织病理学;(g) 抗菌治疗后病情改善的经验证据。我们回顾了这些技术的发展历程,解释了为什么没有一种方法从本质上足以做出非传染性疾病的诊断。因此,我们主张采用共识驱动的多领域方法,建立一个全面、普遍接受的 NVO 定义,以提高研究的可比性、可重复性和流行病学追踪能力。需要持续开展研究工作,进一步完善这些标准,强调专家之间通过德尔菲法开展合作,以实现标准化定义。这项工作旨在简化研究、加快准确诊断、优化诊断工具并有效指导患者护理。
{"title":"It is time for a unified definition of native vertebral osteomyelitis: a framework proposal.","authors":"Francesco Petri, Omar Mahmoud, Said El Zein, Ahmad Nassr, Brett A Freedman, Jared T Verdoorn, Aaron J Tande, Elie F Berbari","doi":"10.5194/jbji-9-173-2024","DOIUrl":"10.5194/jbji-9-173-2024","url":null,"abstract":"<p><p>In recent years, there has been a notable increase in research output on native vertebral osteomyelitis (NVO), coinciding with a rise in its incidence. However, clinical outcomes remain poor, due to frequent relapse and long-term sequelae. Additionally, the lack of a standardized definition and the use of various synonyms to describe this condition further complicate the clinical understanding and management of NVO. We propose a new framework to integrate the primary diagnostic tools at our disposal. These collectively fall into three main domains: clinical, radiological, and direct evidence. Moreover, they and can be divided into seven main categories: (a) clinical features, (b) inflammatory biomarkers, (c) imaging techniques, microbiologic evidence from (d) blood cultures and (e) invasive techniques, (f) histopathology, and (g) empirical evidence of improvement following the initiation of antimicrobial therapy. We provide a review on the evolution of these techniques, explaining why no single method is intrinsically sufficient to formulate an NVO diagnosis. Therefore, we argue for a consensus-driven, multi-domain approach to establish a comprehensive and universally accepted definition of NVO to enhance research comparability, reproducibility, and epidemiological tracking. Ongoing research effort is needed to refine these criteria further, emphasizing collaboration among experts through a Delphi method to achieve a standardized definition. This effort aims to streamline research, expedite accurate diagnoses, optimize diagnostic tools, and guide patient care effectively.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"9 3","pages":"173-182"},"PeriodicalIF":1.8,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-related differences in periprosthetic joint infection research. 假体周围关节感染研究中的性别差异。
Q3 INFECTIOUS DISEASES Pub Date : 2024-04-30 eCollection Date: 2024-01-01 DOI: 10.5194/jbji-9-137-2024
Domenico De Mauro, Cesare Meschini, Giovanni Balato, Tiziana Ascione, Enrico Festa, Davide Bizzoca, Biagio Moretti, Giulio Maccauro, Raffaele Vitiello

Introduction: Periprosthetic joint infections (PJIs) have emerged as a focal point in the realm of orthopedics, garnering widespread attention owing to the escalating incidence rates and the profound impact they impose on patients undergoing total joint arthroplasties (TJAs). Year after year, there has been a growing trend in the analysis of multiple risk factors, complication rates, and surgical treatments in the field. This study aims to illuminate the status of the sex-related differences in periprosthetic joint infections and advance research in this field. Methods: A systematic review was carried out following the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. The final reference list comprised longitudinal studies (both retrospective and prospective) and randomized controlled trials. A sex-based analysis was conducted to assess differences between males and females. Results: A total of 312 studies were initially identified through online database searches and reference investigations. Nine studies were subsequently included in the review. Eight out of nine studies examined the risk of developing PJI after total joint replacement. Notably, only half of these studies demonstrated a statistically significant value, with a p  value  < 0.05 , indicating a higher risk of infectious complications in males compared to females. Conclusion: According to the current literature, there appears to be a propensity for males to develop periprosthetic joint infection after total joint arthroplasty at a higher rate than the female population. Enhancing sex-related analysis in this field is imperative for gathering more robust evidence and insights.

导言:假体周围关节感染(PJIs)已成为骨科领域的一个焦点,由于其发病率不断攀升以及对接受全关节置换术(TJA)的患者造成的深远影响,PJIs 引起了广泛关注。年复一年,该领域对多种风险因素、并发症发生率和手术治疗方法的分析呈增长趋势。本研究旨在阐明假体周围关节感染中与性别相关的差异,并推动该领域的研究。研究方法按照《系统综述和元分析首选报告项目》(PRISMA)指南进行了系统综述。最终的参考文献列表包括纵向研究(包括回顾性研究和前瞻性研究)和随机对照试验。还进行了基于性别的分析,以评估男性和女性之间的差异。结果通过在线数据库搜索和参考文献调查,共初步确定了 312 项研究。随后,9 项研究被纳入审查范围。九项研究中有八项研究了全关节置换术后患 PJI 的风险。值得注意的是,其中只有半数研究的P值为0.05,表明男性感染并发症的风险高于女性。结论:根据目前的文献,男性在全关节置换术后发生假体周围关节感染的几率似乎高于女性。要收集更有力的证据和见解,加强该领域的性别相关分析势在必行。
{"title":"Sex-related differences in periprosthetic joint infection research.","authors":"Domenico De Mauro, Cesare Meschini, Giovanni Balato, Tiziana Ascione, Enrico Festa, Davide Bizzoca, Biagio Moretti, Giulio Maccauro, Raffaele Vitiello","doi":"10.5194/jbji-9-137-2024","DOIUrl":"10.5194/jbji-9-137-2024","url":null,"abstract":"<p><p><b>Introduction</b>: Periprosthetic joint infections (PJIs) have emerged as a focal point in the realm of orthopedics, garnering widespread attention owing to the escalating incidence rates and the profound impact they impose on patients undergoing total joint arthroplasties (TJAs). Year after year, there has been a growing trend in the analysis of multiple risk factors, complication rates, and surgical treatments in the field. This study aims to illuminate the status of the sex-related differences in periprosthetic joint infections and advance research in this field. <b>Methods</b>: A systematic review was carried out following the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. The final reference list comprised longitudinal studies (both retrospective and prospective) and randomized controlled trials. A sex-based analysis was conducted to assess differences between males and females. <b>Results</b>: A total of 312 studies were initially identified through online database searches and reference investigations. Nine studies were subsequently included in the review. Eight out of nine studies examined the risk of developing PJI after total joint replacement. Notably, only half of these studies demonstrated a statistically significant value, with a <math><mi>p</mi></math>  value  <math><mrow><mi><</mi> <mn>0.05</mn></mrow> </math> , indicating a higher risk of infectious complications in males compared to females. <b>Conclusion</b>: According to the current literature, there appears to be a propensity for males to develop periprosthetic joint infection after total joint arthroplasty at a higher rate than the female population. Enhancing sex-related analysis in this field is imperative for gathering more robust evidence and insights.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"9 2","pages":"137-142"},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141419280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing the definition of treatment success alters treatment outcomes in periprosthetic joint infection: a systematic review and meta-analysis. 改变治疗成功的定义会改变假体周围关节感染的治疗效果:系统综述和荟萃分析。
Q3 INFECTIOUS DISEASES Pub Date : 2024-04-26 eCollection Date: 2024-01-01 DOI: 10.5194/jbji-9-127-2024
Eytan M Debbi, Tyler Khilnani, Ioannis Gkiatas, Yu-Fen Chiu, Andy O Miller, Michael W Henry, Alberto V Carli

Background: Variability in the definition of treatment success poses difficulty when assessing the reported efficacy of treatments for hip and knee periprosthetic joint infection (PJI). To address this problem, we determined how definitions of PJI treatment success have changed over time and how this has affected published rates of success after one-stage and two-stage treatments for hip and knee PJI. Methods: A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted to identify one-stage and two-stage revision hip and knee PJI publications in major databases (2006-2021). Definition of treatment success, based on Musculoskeletal Infection Society tier criteria, was identified for each study. Publication year, number of patients, minimum follow-up, and study quality were also recorded. The association of success definitions and treatment success rate was measured using multi-variable meta-regression. Results: Study quality remained unchanged in the 245 publications included. Over time, no antibiotics (tier 1) and no further surgery (tier 3) (40.7 % and 54.5 %, respectively) became the two dominant criteria. After controlling for type of surgery, study quality, study design, follow-up, and year of publication, studies with less strict success definitions (tier 3) reported slightly higher odds ratios of 1.05 [1.01, 1.10] ( p = 0.009 ) in terms of treatment success rates compared to tier 1. Conclusions: PJI researchers have gravitated towards tier-1 and tier-3 definitions of treatment success. While studies with stricter definitions had lower PJI treatment success, the clinical significance of this is unclear. Study quality, reflected in the methodological index for non-randomized studies (MINORS) score, did not improve. We advocate for improving PJI study quality, including clarification of the definition of treatment success.

背景:在评估髋关节和膝关节假体周围感染(PJI)治疗方法的疗效报告时,治疗成功定义的差异会造成困难。为了解决这一问题,我们确定了随着时间的推移,PJI 治疗成功的定义是如何变化的,以及这对已发表的髋关节和膝关节 PJI 一阶段和两阶段治疗后的成功率有何影响。方法:按照《系统综述和荟萃分析首选报告项目》(Preferred Reporting Items for Systematic Reviews and Meta-Analyses,PRISMA)指南进行了系统综述,以确定主要数据库(2006-2021 年)中关于髋关节和膝关节 PJI 一期和二期翻修治疗的出版物。根据肌肉骨骼感染协会的分级标准,确定了每项研究的治疗成功定义。同时还记录了发表年份、患者人数、最低随访时间和研究质量。采用多变量元回归法测量了成功定义与治疗成功率之间的关系。研究结果在纳入的 245 篇论文中,研究质量保持不变。随着时间的推移,无抗生素(第 1 级)和无进一步手术(第 3 级)(分别占 40.7% 和 54.5%)成为两个主要标准。在对手术类型、研究质量、研究设计、随访和发表年份进行控制后,成功定义不那么严格的研究(第 3 级)与第 1 级相比,治疗成功率的几率比略高,为 1.05 [1.01, 1.10] ( p = 0.009)。结论:PJI研究人员倾向于采用第一级和第三级的治疗成功定义。虽然定义更严格的研究的 PJI 治疗成功率较低,但其临床意义尚不明确。以非随机研究方法指数(MINORS)评分反映的研究质量并没有提高。我们主张提高 PJI 研究质量,包括明确治疗成功的定义。
{"title":"Changing the definition of treatment success alters treatment outcomes in periprosthetic joint infection: a systematic review and meta-analysis.","authors":"Eytan M Debbi, Tyler Khilnani, Ioannis Gkiatas, Yu-Fen Chiu, Andy O Miller, Michael W Henry, Alberto V Carli","doi":"10.5194/jbji-9-127-2024","DOIUrl":"10.5194/jbji-9-127-2024","url":null,"abstract":"<p><p><b>Background</b>: Variability in the definition of treatment success poses difficulty when assessing the reported efficacy of treatments for hip and knee periprosthetic joint infection (PJI). To address this problem, we determined how definitions of PJI treatment success have changed over time and how this has affected published rates of success after one-stage and two-stage treatments for hip and knee PJI. <b>Methods</b>: A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted to identify one-stage and two-stage revision hip and knee PJI publications in major databases (2006-2021). Definition of treatment success, based on Musculoskeletal Infection Society tier criteria, was identified for each study. Publication year, number of patients, minimum follow-up, and study quality were also recorded. The association of success definitions and treatment success rate was measured using multi-variable meta-regression. <b>Results</b>: Study quality remained unchanged in the 245 publications included. Over time, no antibiotics (tier 1) and no further surgery (tier 3) (40.7 % and 54.5 %, respectively) became the two dominant criteria. After controlling for type of surgery, study quality, study design, follow-up, and year of publication, studies with less strict success definitions (tier 3) reported slightly higher odds ratios of 1.05 [1.01, 1.10] ( <math><mrow><mi>p</mi> <mo>=</mo> <mn>0.009</mn></mrow> </math> ) in terms of treatment success rates compared to tier 1. <b>Conclusions</b>: PJI researchers have gravitated towards tier-1 and tier-3 definitions of treatment success. While studies with stricter definitions had lower PJI treatment success, the clinical significance of this is unclear. Study quality, reflected in the methodological index for non-randomized studies (MINORS) score, did not improve. We advocate for improving PJI study quality, including clarification of the definition of treatment success.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"9 2","pages":"127-136"},"PeriodicalIF":0.0,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141419279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequent microbiological profile changes are seen in subsequent-revision hip and knee arthroplasty for prosthetic joint infection 在人工关节感染的髋关节和膝关节置换术后,经常出现微生物谱变化
Q3 INFECTIOUS DISEASES Pub Date : 2023-11-03 DOI: 10.5194/jbji-8-229-2023
Robert A. McCulloch, Alex Martin, Bernadette C. Young, Benjamin J. Kendrick, Abtin Alvand, Lee Jeys, Jonathan Stevenson, Antony J. Palmer
Abstract. A proportion of patients with hip and knee prosthetic joint infection (PJI) undergo multiple revisions with the aim of eradicating infection and improving quality of life. The aim of this study was to describe the microbiology cultured from multiply revised hip and knee replacement procedures to guide antimicrobial therapy at the time of surgery. Patients and methods: Consecutive patients were retrospectively identified from databases at two specialist orthopaedic centres in the United Kingdom between 2011 and 2019. Patient were included who had undergone repeat-revision total knee replacement (TKR) or total hip replacement (THR) for infection, following an initial failed revision for infection. Results: A total of 106 patients were identified. Of these patients, 74 underwent revision TKR and 32 underwent revision THR. The mean age at first revision was 67 years (SD 10). The Charlson comorbidity index was ≤ 2 for 31 patients, 3–4 for 57 patients, and ≥ 5 for 18 patients. All patients underwent at least two revisions, 73 patients received three, 47 patients received four, 31 patients received five, and 21 patients received at least six. After six revisions, 90 % of patients had different organisms cultured compared with the initial revision, and 53 % of organisms were multidrug resistant. The most frequent organisms at each revision were coagulase-negative Staphylococcus (36 %) and Staphylococcus aureus (19 %). Fungus was cultured from 3 % of revisions, and 21 % of infections were polymicrobial. Conclusion: Patients undergoing multiple revisions for PJI are highly likely to experience a change in organism, with 90 % of patients having a different organism cultured by their sixth revision. It is therefore important to administer empirical antibiotics at each subsequent revision, taking into account known drug resistance from previous cultures. Our results do not support the routine use of empirical antifungals.
摘要一部分髋关节和膝关节假体感染(PJI)患者接受多次翻修,目的是根除感染,提高生活质量。本研究的目的是描述从多次修改髋关节和膝关节置换术中培养的微生物,以指导手术时的抗菌治疗。患者和方法:从2011年至2019年英国两家专科骨科中心的数据库中回顾性确定连续患者。患者包括因感染而接受重复翻修的全膝关节置换术(TKR)或全髋关节置换术(THR),在首次翻修失败后。结果:共发现106例患者。在这些患者中,74例接受TKR翻修,32例接受THR翻修。首次复查时的平均年龄为67岁(SD 10)。Charlson合并症指数≤2的31例,3-4的57例,≥5的18例。所有患者至少接受了两次翻修,73例接受了3次翻修,47例接受了4次翻修,31例接受了5次翻修,21例接受了至少6次翻修。经过六次修改,90%的患者培养的细菌与最初的版本不同,53%的细菌具有多药耐药。每次修订中最常见的微生物是凝固酶阴性葡萄球菌(36%)和金黄色葡萄球菌(19%)。真菌从3%的修订中培养,21%的感染是多微生物。结论:接受PJI多次翻修的患者极有可能经历生物体的变化,90%的患者在第六次翻修时培养了不同的生物体。因此,重要的是在随后的每次修订中使用经验性抗生素,同时考虑到以前培养的已知耐药性。我们的结果不支持常规使用经验性抗真菌药物。
{"title":"Frequent microbiological profile changes are seen in subsequent-revision hip and knee arthroplasty for prosthetic joint infection","authors":"Robert A. McCulloch, Alex Martin, Bernadette C. Young, Benjamin J. Kendrick, Abtin Alvand, Lee Jeys, Jonathan Stevenson, Antony J. Palmer","doi":"10.5194/jbji-8-229-2023","DOIUrl":"https://doi.org/10.5194/jbji-8-229-2023","url":null,"abstract":"Abstract. A proportion of patients with hip and knee prosthetic joint infection (PJI) undergo multiple revisions with the aim of eradicating infection and improving quality of life. The aim of this study was to describe the microbiology cultured from multiply revised hip and knee replacement procedures to guide antimicrobial therapy at the time of surgery. Patients and methods: Consecutive patients were retrospectively identified from databases at two specialist orthopaedic centres in the United Kingdom between 2011 and 2019. Patient were included who had undergone repeat-revision total knee replacement (TKR) or total hip replacement (THR) for infection, following an initial failed revision for infection. Results: A total of 106 patients were identified. Of these patients, 74 underwent revision TKR and 32 underwent revision THR. The mean age at first revision was 67 years (SD 10). The Charlson comorbidity index was ≤ 2 for 31 patients, 3–4 for 57 patients, and ≥ 5 for 18 patients. All patients underwent at least two revisions, 73 patients received three, 47 patients received four, 31 patients received five, and 21 patients received at least six. After six revisions, 90 % of patients had different organisms cultured compared with the initial revision, and 53 % of organisms were multidrug resistant. The most frequent organisms at each revision were coagulase-negative Staphylococcus (36 %) and Staphylococcus aureus (19 %). Fungus was cultured from 3 % of revisions, and 21 % of infections were polymicrobial. Conclusion: Patients undergoing multiple revisions for PJI are highly likely to experience a change in organism, with 90 % of patients having a different organism cultured by their sixth revision. It is therefore important to administer empirical antibiotics at each subsequent revision, taking into account known drug resistance from previous cultures. Our results do not support the routine use of empirical antifungals.","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"53 17","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135820295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial prophylaxis with teicoplanin plus gentamicin in primary total joint arthroplasty 替柯planin联合庆大霉素在初次全关节置换术中的抗菌预防
Q3 INFECTIOUS DISEASES Pub Date : 2023-10-30 DOI: 10.5194/jbji-8-219-2023
Tariq Azamgarhi, Craig Gerrand, John A. Skinner, Alexander Sell, Robert A. McCulloch, Simon Warren
Abstract. Objectives: To compare prosthetic joint infection (PJI) and acute kidney injury (AKI) rates among cohorts before and after changing our hospital's antimicrobial prophylactic regimen from cefuroxime to teicoplanin plus gentamicin. Methods: We retrospectively studied all patients undergoing primary total joint arthroplasty at our hospital 18 months pre- and post-implementation of the change in practice. All deep infections identified during follow-up were assessed against the European Bone and Joint Infection Society (EBJIS) definitions for PJI. Survival analysis using Cox regression was employed to adjust for differences in baseline characteristics and compare the risk of PJI between the groups. AKIs were identified using pathology records and categorized according to the KDIGO (Kidney Disease – Improving Global Outcomes) criteria. AKI rates were calculated for the pre- and post-intervention periods. Results: Of 1994 evaluable patients, 1114 (55.9 %) received cefuroxime only (pre-intervention group) and 880 (44.1 %) patients received teicoplanin plus gentamicin (post-intervention group). The overall rate of PJI in our study was 1.50 % (30 of 1994), with a lower PJI rate in the post-intervention group (0.57 %; 5 of 880) compared with the pre-intervention group (2.24 %; 25 of 1114). A corresponding risk reduction for PJI of 75.2 % (95 % CI of 35.2–90.5; p=0.004) was seen in the post-intervention group, which was most pronounced for early-onset and delayed infections due to coagulase-negative staphylococci (CoNS) and cefuroxime-resistant Enterobacteriaceae. Significantly higher AKI rates were seen in the post-intervention group; however, 84 % of cases (32 of 38) were stage 1, and there were no differences in the rate of stage-2 or -3 AKI. Conclusions: Teicoplanin plus gentamicin was associated with a significant reduction in PJI rates compared with cefuroxime. Increases in stage-1 AKI were seen with teicoplanin plus gentamicin.
摘要目的:比较我院抗菌预防方案由头孢呋辛改为替柯planin +庆大霉素前后各队列假体关节感染(PJI)和急性肾损伤(AKI)发生率。方法:我们回顾性研究了所有在我院接受首次全关节置换术前后18个月的患者。随访期间发现的所有深部感染均根据欧洲骨和关节感染协会(EBJIS)对PJI的定义进行评估。采用Cox回归的生存分析来调整基线特征的差异,并比较两组之间PJI的风险。根据病理记录确定AKIs,并根据KDIGO(肾脏疾病-改善全球预后)标准进行分类。计算干预前后的AKI发生率。结果:1994例可评估患者中,干预前组仅使用头孢呋辛1114例(55.9%),干预后组使用替柯planin +庆大霉素880例(44.1%)。本研究中PJI总发生率为1.50%(1994年30例),干预后组PJI发生率较低(0.57%;880例中有5例),与干预前组相比(2.24%;25 1114)。PJI的相应风险降低了75.2% (95% CI为35.2-90.5;p=0.004),最明显的是由凝固酶阴性葡萄球菌(con)和头孢呋辛耐药肠杆菌科引起的早发性和延迟性感染。干预后组AKI发生率显著升高;然而,84%的病例(38例中的32例)为1期,2期或3期AKI的发生率没有差异。结论:与头孢呋辛相比,替柯planin加庆大霉素可显著降低PJI发生率。替柯planin加庆大霉素组1期AKI发生率增高。
{"title":"Antimicrobial prophylaxis with teicoplanin plus gentamicin in primary total joint arthroplasty","authors":"Tariq Azamgarhi, Craig Gerrand, John A. Skinner, Alexander Sell, Robert A. McCulloch, Simon Warren","doi":"10.5194/jbji-8-219-2023","DOIUrl":"https://doi.org/10.5194/jbji-8-219-2023","url":null,"abstract":"Abstract. Objectives: To compare prosthetic joint infection (PJI) and acute kidney injury (AKI) rates among cohorts before and after changing our hospital's antimicrobial prophylactic regimen from cefuroxime to teicoplanin plus gentamicin. Methods: We retrospectively studied all patients undergoing primary total joint arthroplasty at our hospital 18 months pre- and post-implementation of the change in practice. All deep infections identified during follow-up were assessed against the European Bone and Joint Infection Society (EBJIS) definitions for PJI. Survival analysis using Cox regression was employed to adjust for differences in baseline characteristics and compare the risk of PJI between the groups. AKIs were identified using pathology records and categorized according to the KDIGO (Kidney Disease – Improving Global Outcomes) criteria. AKI rates were calculated for the pre- and post-intervention periods. Results: Of 1994 evaluable patients, 1114 (55.9 %) received cefuroxime only (pre-intervention group) and 880 (44.1 %) patients received teicoplanin plus gentamicin (post-intervention group). The overall rate of PJI in our study was 1.50 % (30 of 1994), with a lower PJI rate in the post-intervention group (0.57 %; 5 of 880) compared with the pre-intervention group (2.24 %; 25 of 1114). A corresponding risk reduction for PJI of 75.2 % (95 % CI of 35.2–90.5; p=0.004) was seen in the post-intervention group, which was most pronounced for early-onset and delayed infections due to coagulase-negative staphylococci (CoNS) and cefuroxime-resistant Enterobacteriaceae. Significantly higher AKI rates were seen in the post-intervention group; however, 84 % of cases (32 of 38) were stage 1, and there were no differences in the rate of stage-2 or -3 AKI. Conclusions: Teicoplanin plus gentamicin was associated with a significant reduction in PJI rates compared with cefuroxime. Increases in stage-1 AKI were seen with teicoplanin plus gentamicin.","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"139 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136104295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should treatment decisions in septic arthritis of the native hip joint be based on the route of infection? 髋关节脓毒性关节炎的治疗应该基于感染途径吗?
Q3 INFECTIOUS DISEASES Pub Date : 2023-10-12 DOI: 10.5194/jbji-8-209-2023
Fred Ruythooren, Stijn Ghijselings, Jordi Cools, Melissa Depypere, Paul De Munter, Willem-Jan Metsemakers, Georges Vles
Abstract. Background: Surgical management of septic arthritis (SA) of the hip aims at treating the infection by either preserving, resecting or replacing the joint. In some cases, joint preservation should be attempted, whereas other cases would benefit from immediate joint resection or replacement. Prognostic factors have been proposed to guide decision-making. We hypothesized that most of these factors can be simplified to three subgroups based on the route of infection: contiguous spreading, direct inoculation or hematogenous seeding. Methods: A total of 41 patients have been treated surgically for SA of the native hip at our tertiary hospital during the last 16 years. Medical records were studied, and various patient and disease characteristics were collated. Results: Significant differences between (1) level of fitness, (2) condition of the hip joint, (3) micro-organisms and (4) chance of femoral head preservation were found for patients with SA of the native hip resulting from the three aforementioned subgroups. Femoral head resection was necessary at one point in 85 % of patients. Patients with hematogenous infections of undamaged hips had a reasonable chance (53 %) of avoiding joint resection or replacement. Hip arthroplasty was performed on 46.3 % of patients, with an infection rate of 10.5 %. Conclusion: Patients with SA of the native hip resulting from contiguous spreading, hematogenous seeding or direct inoculation differ significantly and should be considered distinct clinical entities. Route of infection is directly related to the chance of femoral head preservation and should, therefore, guide decision-making. Only patients with hematogenous infection to a previously healthy hip had the possibility of femoral head preservation.
摘要背景:髋关节脓毒性关节炎(SA)的外科治疗旨在通过保留、切除或置换关节来治疗感染。在某些情况下,应尝试关节保留,而其他情况下将受益于立即关节切除或置换。人们提出了一些预后因素来指导决策。我们假设这些因素可以根据感染途径简化为三个亚群:连续传播,直接接种或血液播种。方法:我院16年来收治的41例自体髋关节SA患者均行手术治疗。研究了医疗记录,并整理了各种患者和疾病特征。结果:上述三个亚组导致的原髋关节SA患者在(1)健康水平、(2)髋关节状况、(3)微生物和(4)股骨头保存机会之间存在显著差异。在85%的患者中,股骨头切除术是必要的。未损伤髋关节的血液性感染患者有合理的机会(53%)避免关节切除术或置换术。46.3%的患者行髋关节置换术,感染率为10.5%。结论:由于连续扩散、血源性播种或直接接种导致的原髋关节SA患者有显著差异,应视为不同的临床实体。感染途径与股骨头保存的机会直接相关,因此应指导决策。只有先前健康髋关节发生血液性感染的患者才有可能保留股骨头。
{"title":"Should treatment decisions in septic arthritis of the native hip joint be based on the route of infection?","authors":"Fred Ruythooren, Stijn Ghijselings, Jordi Cools, Melissa Depypere, Paul De Munter, Willem-Jan Metsemakers, Georges Vles","doi":"10.5194/jbji-8-209-2023","DOIUrl":"https://doi.org/10.5194/jbji-8-209-2023","url":null,"abstract":"Abstract. Background: Surgical management of septic arthritis (SA) of the hip aims at treating the infection by either preserving, resecting or replacing the joint. In some cases, joint preservation should be attempted, whereas other cases would benefit from immediate joint resection or replacement. Prognostic factors have been proposed to guide decision-making. We hypothesized that most of these factors can be simplified to three subgroups based on the route of infection: contiguous spreading, direct inoculation or hematogenous seeding. Methods: A total of 41 patients have been treated surgically for SA of the native hip at our tertiary hospital during the last 16 years. Medical records were studied, and various patient and disease characteristics were collated. Results: Significant differences between (1) level of fitness, (2) condition of the hip joint, (3) micro-organisms and (4) chance of femoral head preservation were found for patients with SA of the native hip resulting from the three aforementioned subgroups. Femoral head resection was necessary at one point in 85 % of patients. Patients with hematogenous infections of undamaged hips had a reasonable chance (53 %) of avoiding joint resection or replacement. Hip arthroplasty was performed on 46.3 % of patients, with an infection rate of 10.5 %. Conclusion: Patients with SA of the native hip resulting from contiguous spreading, hematogenous seeding or direct inoculation differ significantly and should be considered distinct clinical entities. Route of infection is directly related to the chance of femoral head preservation and should, therefore, guide decision-making. Only patients with hematogenous infection to a previously healthy hip had the possibility of femoral head preservation.","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136013138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report. 天然关节的结核性关节炎——一项系统综述和欧洲骨关节感染学会工作组报告。
Q3 INFECTIOUS DISEASES Pub Date : 2023-08-28 eCollection Date: 2023-01-01 DOI: 10.5194/jbji-8-189-2023
Leonard C Marais, Luan Nieuwoudt, Adisha Nansook, Aditya Menon, Natividad Benito

Introduction: The aim of this systematic review was to assess the existing published data on the diagnosis and management of tuberculosis (TB) arthritis involving native joints in adults aged 18 years and older. Methods: This study was performed in accordance with the guidelines provided in the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR). Results: The systematic review of the literature yielded 20 data sources involving 573 patients from nine countries. There was considerable variation amongst the studies in terms of the approach to diagnosis and management. The diagnosis was mostly made by microbiological tissue culture. Medical management involved a median of 12 months of anti-tubercular treatment (interquartile range, IQR, of 8-16; range of 4-18 months). The duration of preoperative treatment ranged from 2 to 12 weeks. Surgery was performed on 87 % of patients and varied from arthroscopic debridement to complete synovectomies combined with total joint arthroplasty. The mean follow-up time of all studies was 26 months (range of 3-112 months). Recurrence rates were reported in most studies, with an overall average recurrence rate of approximately 7.4 % (35 of 475 cases). Conclusions: The current literature on TB arthritis highlights the need for the establishment of standardized guidelines for the confirmation of the diagnosis. Further research is needed to define the optimal approach to medical and surgical treatment. The role of early debridement in active TB arthritis needs to be explored further. Specifically, comparative studies are required to address questions around the use of medical treatment alone vs. in combination with surgical intervention.

引言:本系统综述的目的是评估18岁及以上成年人肺结核(TB)关节炎的诊断和治疗的现有已发表数据。方法:本研究根据系统评价的首选报告项目和范围界定评价的荟萃分析扩展(PRISMA ScR)中提供的指南进行。结果:对文献的系统回顾产生了20个数据来源,涉及来自9个国家的573名患者。在诊断和管理方法方面,研究之间存在相当大的差异。诊断主要是通过微生物组织培养。医疗管理涉及抗结核治疗的中位数为12个月(四分位数间IQR为8-16;范围为4-18个月)。术前治疗时间为2至12周。手术于87 % 从关节镜下清创到完全滑膜切除联合全关节置换术。所有研究的平均随访时间为26个月(3-112个月)。大多数研究报告了复发率,总体平均复发率约为7.4 % (475例中有35例)。结论:目前关于结核性关节炎的文献强调了建立标准化诊断指南的必要性。需要进一步的研究来确定最佳的医疗和外科治疗方法。早期清创术在活动性结核性关节炎中的作用有待进一步探讨。具体而言,需要进行比较研究,以解决单独使用药物治疗与联合使用手术干预的问题。
{"title":"Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.","authors":"Leonard C Marais,&nbsp;Luan Nieuwoudt,&nbsp;Adisha Nansook,&nbsp;Aditya Menon,&nbsp;Natividad Benito","doi":"10.5194/jbji-8-189-2023","DOIUrl":"https://doi.org/10.5194/jbji-8-189-2023","url":null,"abstract":"<p><p><b>Introduction</b>: The aim of this systematic review was to assess the existing published data on the diagnosis and management of tuberculosis (TB) arthritis involving native joints in adults aged 18 years and older. <b>Methods</b>: This study was performed in accordance with the guidelines provided in the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR). <b>Results</b>: The systematic review of the literature yielded 20 data sources involving 573 patients from nine countries. There was considerable variation amongst the studies in terms of the approach to diagnosis and management. The diagnosis was mostly made by microbiological tissue culture. Medical management involved a median of 12 months of anti-tubercular treatment (interquartile range, IQR, of 8-16; range of 4-18 months). The duration of preoperative treatment ranged from 2 to 12 weeks. Surgery was performed on 87 % of patients and varied from arthroscopic debridement to complete synovectomies combined with total joint arthroplasty. The mean follow-up time of all studies was 26 months (range of 3-112 months). Recurrence rates were reported in most studies, with an overall average recurrence rate of approximately 7.4 % (35 of 475 cases). <b>Conclusions</b>: The current literature on TB arthritis highlights the need for the establishment of standardized guidelines for the confirmation of the diagnosis. Further research is needed to define the optimal approach to medical and surgical treatment. The role of early debridement in active TB arthritis needs to be explored further. Specifically, comparative studies are required to address questions around the use of medical treatment alone vs. in combination with surgical intervention.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"8 4","pages":"189-207"},"PeriodicalIF":0.0,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41178950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A natural history of untreated chronic osteomyelitis of the tibia over 20 years, with evolving squamous cell carcinoma: a case report. 20年以上未经治疗的胫骨慢性骨髓炎伴鳞状细胞癌的自然史:一例报告。
Q3 INFECTIOUS DISEASES Pub Date : 2023-08-02 eCollection Date: 2023-01-01 DOI: 10.5194/jbji-8-183-2023
Asanka Wijendra, Alex Ramsden, Martin McNally

Squamous cell carcinoma (SCC) is a rare but potentially life-threatening complication of chronic osteomyelitis. Whilst there have been over 100 cases of chronic osteomyelitis with malignant transformation reported in the literature between 1999 and 2020, this is the first case report to document transformation with 20 years of concordant imaging and clinical review.

鳞状细胞癌是一种罕见但可能危及生命的慢性骨髓炎并发症。虽然在1999年至2020年期间,文献中报道了100多例慢性骨髓炎伴恶性转化的病例,但这是第一例通过20年一致的影像学和临床审查记录转化的病例报告。
{"title":"A natural history of untreated chronic osteomyelitis of the tibia over 20 years, with evolving squamous cell carcinoma: a case report.","authors":"Asanka Wijendra,&nbsp;Alex Ramsden,&nbsp;Martin McNally","doi":"10.5194/jbji-8-183-2023","DOIUrl":"10.5194/jbji-8-183-2023","url":null,"abstract":"<p><p>Squamous cell carcinoma (SCC) is a rare but potentially life-threatening complication of chronic osteomyelitis. Whilst there have been over 100 cases of chronic osteomyelitis with malignant transformation reported in the literature between 1999 and 2020, this is the first case report to document transformation with 20 years of concordant imaging and clinical review.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"8 4","pages":"183-188"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41101728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dalbavancin is thermally stable at clinically relevant temperatures against methicillin-sensitive Staphylococcus Aureus. 达尔巴万星在临床相关温度下对甲氧西林敏感的金黄色葡萄球菌具有热稳定性。
Q3 INFECTIOUS DISEASES Pub Date : 2023-06-28 eCollection Date: 2023-01-01 DOI: 10.5194/jbji-8-175-2023
Aaron K Hoyt, Patrick Lawler, Mathias Bostrom, Alberto V Carli, Ashley E Levack

Introduction: While the rate of orthopaedic infections has remained constant over the years, the burden on healthcare systems continues to rise with an aging population. Local antibiotic delivery via polymethyl methacrylate bone cement is a common adjunct in treating bone and joint infections. Dalbavancin is a novel lipoglycopeptide antibiotic in the same class as vancomycin that has shown efficacy against Gram-positive organisms when used systemically but has not been investigated as a local antibiotic. This study aims to identify whether dalbavancin is thermally stable at the temperatures expected during the polymerization of polymethyl methacrylate cement. Methods: Stock solutions of dalbavancin were prepared and heated using a polymerase chain reaction machine based upon previously defined models of curing temperatures in two clinically relevant models: a 10 mm polymethyl methacrylate bead and a polymethyl methacrylate articulating knee spacer model. Aliquots of heated dalbavancin were then transferred to be incubated at core body temperature (37 C) and analyzed at various time points up to 28 d. The minimum inhibitory concentration at which 90 % of colonies were inhibited (MIC90) for each heated sample was determined against methicillin-sensitive Staphylococcus aureus (American Type Culture Collection, ATCC, 0173K) using a standard microbroth dilution assay. Results: The average MIC90 of dalbavancin was 1.63 µgmL-1 ±0.49 against 0173K S. aureus. There were no significant differences in the relative MIC90 values after heating dalbavancin in either model compared to unheated control dalbavancin. Conclusions: Dalbavancin is thermally stable at the curing temperatures of polymethyl methacrylate cement and at human core body temperature over 28 d. Future in vitro and in vivo studies are warranted to further investigate the role of dalbavancin as a local antibiotic prior to its clinical use.

引言:尽管骨科感染率多年来一直保持不变,但随着人口老龄化,医疗系统的负担继续增加。通过聚甲基丙烯酸甲酯骨水泥进行局部抗生素递送是治疗骨和关节感染的常见辅助手段。达尔巴万星是一种与万古霉素同属一类的新型脂糖肽抗生素,在全身使用时对革兰氏阳性菌显示出疗效,但尚未作为局部抗生素进行研究。本研究旨在确定达尔巴万星在聚甲基丙烯酸甲酯水泥聚合过程中的预期温度下是否具有热稳定性。方法:根据先前定义的两种临床相关模型中的固化温度模型,制备达尔巴万星储备溶液,并使用聚合酶链式反应机加热: mm聚甲基丙烯酸甲酯珠和聚甲基丙烷关节膝部垫片模型。然后转移加热的dalbavancin的等分试样以在核心体温下孵育(37 ∘C) 并在截至28的不同时间点进行分析 d.90 % 使用标准microbroth稀释测定法针对甲氧西林敏感的金黄色葡萄球菌(American Type Culture Collection,ATCC,0173K)测定每个加热样品的菌落被抑制(MIC90)。结果:达巴万星的MIC90平均值为1.63 µgmL-1±0.49对抗0173K金黄色葡萄球菌。与未加热的对照组相比,两种模型中加热达尔巴万星后的相对MIC90值均无显著差异。结论:达尔巴万星在聚甲基丙烯酸甲酯水泥的固化温度和人体核心体温超过28℃时是热稳定的 d.未来的体外和体内研究有必要在临床使用前进一步研究达尔巴万星作为局部抗生素的作用。
{"title":"Dalbavancin is thermally stable at clinically relevant temperatures against methicillin-sensitive <i>Staphylococcus Aureus</i>.","authors":"Aaron K Hoyt, Patrick Lawler, Mathias Bostrom, Alberto V Carli, Ashley E Levack","doi":"10.5194/jbji-8-175-2023","DOIUrl":"10.5194/jbji-8-175-2023","url":null,"abstract":"<p><p><b>Introduction</b>: While the rate of orthopaedic infections has remained constant over the years, the burden on healthcare systems continues to rise with an aging population. Local antibiotic delivery via polymethyl methacrylate bone cement is a common adjunct in treating bone and joint infections. Dalbavancin is a novel lipoglycopeptide antibiotic in the same class as vancomycin that has shown efficacy against Gram-positive organisms when used systemically but has not been investigated as a local antibiotic. This study aims to identify whether dalbavancin is thermally stable at the temperatures expected during the polymerization of polymethyl methacrylate cement. <b>Methods</b>: Stock solutions of dalbavancin were prepared and heated using a polymerase chain reaction machine based upon previously defined models of curing temperatures in two clinically relevant models: a 10 mm polymethyl methacrylate bead and a polymethyl methacrylate articulating knee spacer model. Aliquots of heated dalbavancin were then transferred to be incubated at core body temperature (37 <math><msup><mi></mi><mo>∘</mo></msup></math>C) and analyzed at various time points up to 28 d. The minimum inhibitory concentration at which 90 % of colonies were inhibited (MIC<math><msub><mi></mi><mn>90</mn></msub></math>) for each heated sample was determined against methicillin-sensitive <i>Staphylococcus aureus</i> (American Type Culture Collection, ATCC, 0173K) using a standard microbroth dilution assay. <b>Results</b>: The average MIC<math><msub><mi></mi><mn>90</mn></msub></math> of dalbavancin was 1.63 <math><mrow><mi>µ</mi><mi>g</mi><mspace></mspace><msup><mi>mL</mi><mrow><mo>-</mo><mn>1</mn></mrow></msup></mrow></math> <math><mrow><mo>±</mo><mn>0.49</mn></mrow></math> against 0173K <i>S. aureus</i>. There were no significant differences in the relative MIC<math><msub><mi></mi><mn>90</mn></msub></math> values after heating dalbavancin in either model compared to unheated control dalbavancin. <b>Conclusions</b>: Dalbavancin is thermally stable at the curing temperatures of polymethyl methacrylate cement and at human core body temperature over 28 d. Future in vitro and in vivo studies are warranted to further investigate the role of dalbavancin as a local antibiotic prior to its clinical use.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"8 3","pages":"175-181"},"PeriodicalIF":0.0,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41116764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The antibiotic bead pouch - a useful technique for temporary soft tissue coverage, infection prevention and therapy in trauma surgery. 抗生素珠袋-一种在创伤手术中用于临时软组织覆盖、感染预防和治疗的有用技术。
Q3 INFECTIOUS DISEASES Pub Date : 2023-06-21 eCollection Date: 2023-01-01 DOI: 10.5194/jbji-8-165-2023
Markus Rupp, Nike Walter, Dominik Szymski, Christian Taeger, Martin Franz Langer, Volker Alt

Soft tissue defects resulting from trauma and musculoskeletal infections can complicate surgical treatment. Appropriate temporary coverage of these defects is essential to achieve the best outcomes for necessary plastic soft tissue defect reconstruction. The antibiotic bead pouch technique is a reasonable surgical approach for managing temporary soft tissue defects following adequate surgical debridement. This technique involves the use of small diameter antibiotic-loaded bone cement beads to fill the dead space created by debridement. By applying antibiotics to the bone cement and covering the beads with an artificial skin graft, high local dosages of antibiotics can be achieved, resulting in the creation of a sterile wound that offers the best starting position for soft tissue and bone defect reconstruction. This narrative review describes the rationale for using this technique, including its advantages and disadvantages, as well as pearls and pitfalls associated with its use in daily practice. In addition, the article provides a comprehensive overview of the literature that has been published since the technique was introduced in surgical practice.

创伤和肌肉骨骼感染引起的软组织缺损可能使外科治疗复杂化。对这些缺陷进行适当的临时覆盖对于实现必要的塑性软组织缺陷重建的最佳结果至关重要。抗生素珠袋技术是一种合理的手术方法,可以在充分的外科清创术后处理暂时性软组织缺陷。这项技术包括使用小直径的载有抗生素的骨水泥珠来填充清创术产生的死区。通过在骨水泥上应用抗生素并用人造皮肤移植物覆盖珠粒,可以实现高局部剂量的抗生素,从而产生无菌伤口,为软组织和骨缺损重建提供最佳起始位置。这篇叙述性综述描述了使用这种技术的基本原理,包括它的优点和缺点,以及与日常实践中使用它相关的珍珠和陷阱。此外,这篇文章对自该技术被引入外科实践以来发表的文献进行了全面综述。
{"title":"The antibiotic bead pouch - a useful technique for temporary soft tissue coverage, infection prevention and therapy in trauma surgery.","authors":"Markus Rupp,&nbsp;Nike Walter,&nbsp;Dominik Szymski,&nbsp;Christian Taeger,&nbsp;Martin Franz Langer,&nbsp;Volker Alt","doi":"10.5194/jbji-8-165-2023","DOIUrl":"10.5194/jbji-8-165-2023","url":null,"abstract":"<p><p>Soft tissue defects resulting from trauma and musculoskeletal infections can complicate surgical treatment. Appropriate temporary coverage of these defects is essential to achieve the best outcomes for necessary plastic soft tissue defect reconstruction. The antibiotic bead pouch technique is a reasonable surgical approach for managing temporary soft tissue defects following adequate surgical debridement. This technique involves the use of small diameter antibiotic-loaded bone cement beads to fill the dead space created by debridement. By applying antibiotics to the bone cement and covering the beads with an artificial skin graft, high local dosages of antibiotics can be achieved, resulting in the creation of a sterile wound that offers the best starting position for soft tissue and bone defect reconstruction. This narrative review describes the rationale for using this technique, including its advantages and disadvantages, as well as pearls and pitfalls associated with its use in daily practice. In addition, the article provides a comprehensive overview of the literature that has been published since the technique was introduced in surgical practice.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"8 3","pages":"165-173"},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41202170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Bone and Joint Infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1